Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/MYLAN-N-V-21077045/news/Mylan-Invalidates-Two-of-Teva-s-Copaxone-40-mg-mL-Patents-Via-U-S-Patent-and-Trademark-Office-s-22950606/?utm_source=whatsapp&utm_medium=social&utm_campaign=share